<DOC>
	<DOCNO>NCT01802580</DOCNO>
	<brief_summary>To evaluate whether participation Internet-based intervention help improve short-term long-term psoriasis treatment outcome , particular , adherence .</brief_summary>
	<brief_title>Using Internet Study Improve Adherence Psoriasis Patients</brief_title>
	<detailed_description>An investigator-blinded , prospective study subject mild moderate psoriasis conduct . Forty subject age 18 year old enrolled.The Internet-based survey pilot evaluate effect adherence topical psoriasis medication . Subjects randomize 1:1 ratio Internet-survey group log impression state psoriasis weekly basis . Subjects intervention control group receive standard-of-care topical fluocinonide 0.05 % ointment apply affected area skin twice daily . Adherence fluocinonide assess use Medication Event Monitoring System ( MEMSÂ® ) cap , electronic monitor affix medication container . Investigators subject blind adherence data final ( Month 12 ) treatment visit .</detailed_description>
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Fluocinonide</mesh_term>
	<criteria>Any male female 18 year old age diagnosis mild moderate psoriasis dermatologist eligible participation . Less 20 % body surface involvement psoriasis . Subject capable understanding willing provide sign dated write voluntary informed consent protocol specific procedure perform . The subject able complete study comply study instruction , include attend study visit . In general good health skin disease , disease state physical condition would impair evaluation psoriasis would increase health risk study participation Individuals young 18 year age . Known allergy sensitivity topical fluocinonide . Inability complete studyrelated visit , inability complete Internet survey due inadequate Internet access . Introduction prescription medication , topical systemic , psoriasis participate study . Subjects systemic antiinflammatory treatment psoriasis must stable dose least 3 month prior enrollment . Any skin condition disease may require concurrent therapy may confound evaluation Current enrollment research study involve investigational drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>